OCPH: ATH 342 Reached, But Valuation Is Getting Extreme October Pharma Co.EGX_DLY:OCPHmnmabroukw36ix📊 OCPH: ATH 342 Reached, But Valuation Is Getting Extreme 🚀 🧱 Fundamentals: OCPH, like many pharmaceutical stocks in the EGX medical sector, has become extremely expensive after the massive rally. ⚠️ The current valuation leaves very little margin of safety for new investors at these levels. 📉 From a fundamental perspective, my fair value entry is around 233 EGP, while the more conservative entry zone is around 180 EGP. 🎯 I believe sooner or later the price will retest these valuation levels and create a much healthier risk/reward opportunity. 📊 📊 The Pulse: OCPH has already reached the previous target around 322 EGP and pushed further to a new ATH at 342 EGP. 🚀 The momentum remains extremely strong, and there is currently no technical reason to call the uptrend finished. 📈 As long as both major trend lines remain intact, the stock remains inside its bullish wave. 🔥 However, the distance between the current price and fundamental fair value is becoming increasingly large. ⚠️ This makes chasing the stock at current levels increasingly risky, even while the technical structure remains bullish. 📉 A future pullback toward 233 EGP would bring the valuation closer to a reasonable entry level, while 180 EGP would represent a much more conservative opportunity. 🎯 🧱 The Key Structural Boundaries: Breakout Trigger: Holding both major uptrend lines keeps the bullish wave active. 🚀 First Target: ATH at 342 EGP. 🎯 Second Target: Further upside will depend on continuation of the current momentum wave. 📈 Final Target: New targets will be updated if the stock establishes a confirmed breakout above the current ATH. 🚀 ⚠️ Risk Management: The main risk is not the current technical trend, but the extremely stretched valuation. ⚠️ A break below the major trend lines would be the first serious warning that the bullish wave is losing momentum. 📉 I would avoid chasing the stock and instead wait for a meaningful correction toward the fundamental valuation zones. 🎯 ☪️ Sharia Compliance: Status: Eligible according to the provided screening information. ✅ The latest financial statements should continue to be checked against the applicable EGX Shariah Index Supervisory Committee criteria before making a final compliance decision. 📋 🎯 Verdict: OCPH remains technically bullish after reaching 322 EGP and printing a new ATH at 342 EGP. 🚀 But fundamentally, the stock has become extremely expensive and the risk/reward for fresh entries is no longer attractive. ⚠️ My preferred fair value entry is around 233 EGP, while the conservative level is around 180 EGP. 🎯 Until a meaningful pullback happens, I would rather watch the bullish trend than chase the price at extreme valuations. 📊 If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑